Journal of the American Society of Hypertension
Volume 2, Issue 4 , Pages 275-285 , July 2008

Long-term high-salt diet causes hypertension and decreases renal expression of vascular endothelial growth factor in Sprague-Dawley rats

Received 10 December 2007 ,Accepted 10 March 2008.

References 

  1. Aviv A. Salt and hypertension: the debate that begs the bigger question. Arch Intern Med. 2001;161:507–510
  2. Frolich ED, Varagic J. Sodium directly impairs target organ function in hypertension. Curr Opin Cardiol. 2005;20:424–429
  3. Gu JW, Anand V, Shek EW, Moore MC, Brady AL, Kelly WC, et al. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension. 1998;31:1083–1087
  4. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet (SASH-Sodium Collaborative Research Group). N Engl J Med. 2001;344:3–10
  5. Meneton P, Jeunemaitre X, de Wardener HE, Macgregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005;85:679–715
  6. Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science. 1991;252:1813–1816
  7. Hall JE, Guyton AC, Smith MJ, Coleman TG. Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin. Am J Physiol Renal Fluid Electrolyte Physiol. 1980;239:F271–F280
  8. Masson GMC, Aoki K, Page IH. Effects of sinoaortic denervation on renal and adrenal hypertension. Am J Physiol. 1966;211:94–104
  9. Dzielak DJ, Norman RA. Renal nerves are not necessary for onset or maintenance of DOCA-salt hypertension in rats. Am J Physiol Heart Circ Physiol. 1985;249:H945–H949
  10. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. 1996;27:481–490
  11. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure (Results for 24-hour urinary sodium and potassium excretion). BMJ. 1988;297:319–328
  12. Poulter N, Khaw KT, Hopwood BEC, Mugambi M, Peart WS, Rose G, et al. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ. 1990;300:967–972
  13. Forte JG, Miguel JM, Miguel MJ, de Padua F, Rose G. Salt and blood pressure: a community trial. J Hum Hypertens. 1989;3:179–184
  14. Lifton RP. Molecular genetics of human blood pressure variations. Science. 1996;272:676–680
  15. Corbett WT, Kuller LH, Blaine EH, Damico FJ. Utilization of swine to study the risk factor of an elevated salt diet on blood pressure. Am J Clin Nutr. 1979;32:2068–2075
  16. Cherchovich GM, Capek K, Jefremova Z, Pohlova I, Jelinek J. High salt intake and blood pressure in lower primates (Papio hamadryas). J Appl Physiol. 1976;40:601–604
  17. Srinivasan SR, Dalferes ER, Wolf RH, Radhakrishnamurthy B, Foster TA, Berenson GS. Variability in blood pressure response to dietary sodium intake among African green monkeys (Cercopithecus aethiops). Am J Clin Nutr. 1984;39:792–796
  18. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, et al. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med. 1995;1:1009–1016
  19. Manning RD, Tian N, Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol. 2005;25:311–317
  20. Gu JW, Tian N, Shparago M, Tan W, Bailey AP, Manning RD. Renal NF-κB activation and TNF-α upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol. 2006;291:R1817–R1824
  21. Brooks VL, Freeman KL, Qi Y. Time course of synergistic interaction between DOCA and salt on blood pressure: roles of vasopressin and hepatic osmoreceptors. Am J Physiol Regul Integr Comp Physiol. 2006;91:R1825–R1834
  22. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545–556
  23. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol. 2004;286:F606–F616
  24. Vaziri ND, Rodriguez-Iturbe B. Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nature Clin Prac Nephrol. 2006;2:582–593
  25. Sandler AB, Johnson DH, Hertst RS. Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer. Clin Cancer Res. 2004;10:4258S–4262S
  26. Holden SN, Eckhardt SG, Basser R, de Boer R, Rischin D, Green M, et al. Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and VEGF receptor signaling, in patients with solid, malignant tumors. Ann Oncol. 2005;16:1391–1397
  27. Zangari M, Anaissie E, Stopeck A, Morimoto A, Tan N, Lancet J, et al. Phase II study of SU5416, a small molecular vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma. Clin Cancer Res. 2004;10:88–95
  28. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of pre-eclampsia. N Engl J Med. 2004;350:72–83
  29. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal disease. J Clin Invest. 2003;111:707–716
  30. Kang DH, Kim YG, Andoh TF, Gordon KL, Suga SI, Mazzali M, et al. Post-cyclosporin-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor. Am J Physiol Renal Physiol. 2001;280:F727–F736
  31. Yau HT, Li XZ, Pitera JE, Long DA, Woolf AS. Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia inducible factor-1α. Am J Pathol. 2003;163:2289–2301
  32. Pillebout E, Burtin M, Yuan HT, Briand P, Woolf AS, Friedlander G, et al. Proliferation remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesion. Am J Pathol. 2001;159:547–560
  33. Gu JW, Llnas MT, Wang J, Stockton A, Adair TH. Low dietary salt intake induces mRNA expression of vascular endothelial growth factor in kidneys of WKY rats. Am J Hypertension. 2002;15:128A–129A
  34. Gu JW, Elam J, Sartin A, Li W, Roach R, Adair TH. Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulation angiogenesis. Am J Physiol Regulatory Integrative Comp Physiol. 2001;281:R368–R721
  35. Siegel AK, Kossmehl P, Planer M, Schulz A, Wehland M, Stoll M, et al. Genetic linkage of albuminuria and renal injury in Dahl salt-sensitive rats on a high-salt diet: comparison with spontaneously hypertensive rats. Physiol Genomics. 2004;18:218–225
  36. Farjah M, Washington TL, Roxas BP, Geenen DL, Danziger RS. Dietary NaCl regulates renal aminopeptidase N: relevance to hypertension in the Dahl rat. Hypertension. 2004;43:282–285
  37. Mattson DL, Higgins DJ. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension. 1996;27:688–692
  38. Titze J, Luft FC, Bauer K, Dietsch P, Lang R, Veelken R, et al. Extrarenal Na+ balance, volume, and blood pressure homeostasis in intact and ovariectomized deoxycorticosterone-acetate salt rats. Hypertension. 2006;47:1101–1107
  39. Dahl LK, Heine M, Tassinari L. Effects of chronic excess salt ingestion (Role of genetic factors in both doca-salt and renal hypertension). J Exp Med. 1963;118:605–617
  40. DiBona GF, Sawin LL. Exaggerated natriuresis in experimental hypertension. Proc Soc Exp Biol Med. 1986;182:43–51
  41. Praga M, Morales E. Renal damage associated with proteinuria. Kidney Int. 2002;62:S42–S46
  42. Roy H, Bhardwaj S, Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett. 2006;580:2879–2887
  43. Pupilli C, Lasagni L, Romagnani P, Bellini F, Mannelli M, Misciglia N, et al. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. Am J Soc Nephrol. 1999;10:245–255
  44. Shihab FS, Bennett WM, Isaac J, Yi H, Andoh TF. Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity. Kidney Int. 2002;62:422–433
  45. Rizkalla B, Forbes JM, Cooper ME, Cao Z. Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors. Am J Soc Nephrol. 2003;14:3061–3071
  46. Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int. 1999;56:794–814
  47. Schrijvers BF, Flyvbjerg A, DeVriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004;65:2003–2017
  48. Villegas G, Lange-Sperandio B, Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int. 2005;67:449–457
  49. Hara A, Wada T, Furuichi K, Sakai N, Kawachi H, Shimizu F, et al. Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis. Kidney Int. 2006;69:1986–1995
  50. Sugimoto H, Hamano Y, Charyta D, Cosgrove D, Kieran M, Sudhakar A, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem. 2003;278:12605–12608
  51. Hornig C, Barleon B, Ahmad S, et al. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids. Lab Invest. 2000;80:443–454

 This work was supported by the National Heart, Lung, and Blood Institute Grant HL-51971 and the National Institute on Alcohol Abuse and Alcoholism Grant AA-013821-01A2.

 Conflict of interest: none.

PII: S1933-1711(08)00036-3

doi: 10.1016/j.jash.2008.03.001

Journal of the American Society of Hypertension
Volume 2, Issue 4 , Pages 275-285 , July 2008

Article Tools

* Image Usage & Resolution